Abstract
The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days.
| Original language | English |
|---|---|
| Pages (from-to) | 930-932 |
| Number of pages | 3 |
| Journal | American Journal of Infection Control |
| Volume | 41 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 10-2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Epidemiology
- Health Policy
- Public Health, Environmental and Occupational Health
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver